CUTANEOUS ANGIOSARCOMA
Clinical trials for CUTANEOUS ANGIOSARCOMA explained in plain language.
Never miss a new study
Get alerted when new CUTANEOUS ANGIOSARCOMA trials appear
Sign up with your email to follow new studies for CUTANEOUS ANGIOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New attack on deadly skin cancer: Double-Duty treatment before surgery
Disease control OngoingThis study is testing a two-step treatment for a rare and aggressive skin cancer called angiosarcoma. First, patients receive a chemotherapy drug (paclitaxel) for several weeks, then they continue that drug while also receiving radiation therapy. The goal is to shrink the tumor a…
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Virus + drug combo targets Tough-to-Treat sarcomas
Disease control OngoingThis study is testing whether combining two immunotherapy drugs can help control advanced sarcoma, a rare and aggressive cancer. The trial is for adults with certain types of sarcoma that have spread or cannot be surgically removed, and who have typically tried at least one other…
Matched conditions: CUTANEOUS ANGIOSARCOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC